Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma;Belangrijke prognostische betekenis van schildwachtklierbiopsie bij patiënten met maligne melanoom

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 18, 2004, Pages 884-888

  Keijzer, R ^a,b   Bril, H ^a,b   Van Der Loo, E M ^a,b   De Graaf, P W ^a,b  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b Afd Chirurgie ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON ALPHA2A;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; FEMALE; FOLLOW UP; GAMMA SCINTIGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; METASTASIS; NETHERLANDS; OUTCOMES RESEARCH; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCHOOL CHILD; SENTINEL LYMPH NODE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 2442511164     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. McMasters KM, Swetter SM. Current management of melanoma: benefits of surgical staging and adjuvant therapy. J Surg Oncol 2003;82:209-16.
3. Kroon BB, Bergman W, Coebergh JW, Ruiter DJ. Tweede herziene consensus melanoom van de huid. Ned Tijdschr Geneeskd 1997; 141:2015-9.
4. Eggermont AM, Keilholz U, Testori A, Cook M, Lienard D, Ruiter DJ. The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. Ann Surg Oncol 2001;8(9 Suppl):38S-40S.
5. Kroon BBR, Welvaart K, Eggermont AMM. Electieve (profylactische) lymfklierdissectie. In: Richtlijn melanoom van de huid. Utrecht: Centraal Begeleidingsorgaan voor de Intercollegiale Toetsing CBO; 1997. p. 40-3.
6. Vuylsteke RJ, Leeuwen PA van, Statius Muller MG, Gietema HA, Kragt DR, Meijer S. Clinical outcome of stage IIII melanoma patients after selective sentinel lymph node dissection: long-term follow-up results. J Clin Oncol 2003;21:1057-65.
7. Statius Muller MG, Leeuwen PA van, Diest PJ van, Vuylsteke RJ, Pijpers R, Meijer S. No indication for performing sentinel node biopsy in melanoma patients with a Breslow thickness of less than 0.9 mm. Melanoma Res 2001;11:303-7.
8. Loo EM van der, Hop WCJ Tervoort MA, Graaf PW de. Zeer geringe kans op andere kliermetastasen in de oksel bij borstkankerpatiënten met een kleine schildwachtkliermetastase zonder extranodale tumorgroei. Ned Tijdschr Geneeskd [ter perse].
9. Carlson GW, Murray DR, Lyles RH, Staley CA, Hestley A, Cohen C. The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance? Ann Surg Oncol 2003;10:575-81.
10. Statius Muller MG, Leeuwen PA van, Lange-de Klerk ES de, Diest PJ van, Pijpers R, Ferwerda CC, et al. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with stage I or II cutaneous melanoma. Cancer 2001;91:2401-8.
11. Estourgie SH, Nieweg OE, Valdes Olmos RA, Hoefnagel CA, Kroon BB. Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years. Ann Surg Oncol 2003;10:681-8.
12. Gershenwald JE, Thompson W, Mansfield PF, Lee JE, Colome MI, Tseng CH, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-83.
13. McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A, et al. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001;19: 2851-5.
14. Nieweg OE, Eggermont AMM, Kroon BBR. Schildwachtklierbiopsie bij melanoom: kritische vragen. Ned Tijdschr Geneeskd 2002; 146:1774-7.